7 - Moderated Panel Discussion on Adaptive Trials

Wednesday, October 19, 2022

2:30 PM – 3:15 PM US ET

Location: 147 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Panelist(s)

Steven Tong, MBBS, Hon FRACP, PhD

Clinician scientist
Doherty Institute, University of Melbourne

Disclosure: Disclosure(s): Roivant Sciences: Advisor/Consultant (Ongoing)
Jens Lundgren, MD DMSc

Professor
Rigshospitalet, University of Copenhagen
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): No financial relationships to disclose
Anna McGlothlin, PhD

Director and Senior Statistical Scientist
Berry Consultants
Austin, Texas, United States

Disclosure: Disclosure(s): Multiple: Advisor/Consultant (Ongoing)
Susanna Naggie, MD/MHS

Professor of Medicine with Tenure/Vice Dean of Clinical Research
DCRI/ School of Medicine
Durham, North Carolina, United States

Disclosure: Disclosure(s): AbbVie: Grant/Research Support (); BMS/PRA: Event adjudication (); Gilead Sciences: Grant/Research Support (); Pardes Biosciences: Advisor/Consultant (); Personal Health Insights, Inc: Data Safety Monitoring Board Member (); Silverback Therapeutics: Advisor/Consultant (); Vir Biotechnology: Advisor/Consultant (), Stocks/Bonds ()

Disclosure(s):

Steven Tong, MBBS, Hon FRACP, PhD: Roivant Sciences: Advisor/Consultant (Ongoing)

Jens Lundgren, MD DMSc: No financial relationships to disclose

Anna McGlothin, PhD: Multiple: Advisor/Consultant (Ongoing)

Susanna Naggie, MD/MHS: AbbVie: Grant/Research Support (); BMS/PRA: Event adjudication (); Gilead Sciences: Grant/Research Support (); Pardes Biosciences: Advisor/Consultant (); Personal Health Insights, Inc: Data Safety Monitoring Board Member (); Silverback Therapeutics: Advisor/Consultant (); Vir Biotechnology: Advisor/Consultant (), Stocks/Bonds ()